CANADIAN NATIONAL STOCK EXCHANGE · DRUG

0.00% · $0.0000 · Vol 67.9K

Market closed · last close 4:00 PM ET · price as of 16:01:29 ET

Bright Minds Biosciences Inc

Biotechnology

$52.00

Card

Relationship Map

Follow $DRUG

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $DRUG by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measured

Stale score · Wed Oct 7 · completed session · 28h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET · DRUG

Methodology

Thu Oct 8 snapshot unavailable for DRUG. Cause unavailable.

Earnings absence reason unknown

DRUG

Bright Minds Biosciences Inc

Stale score · Wed Oct 7 · completed session · 28h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET

42/100

Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

42/ 100

Veridion Score

Lower range · MEDIUM confidence · 5 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: MEDIUM · 5 of 6 factors measured · Stale score · Wed Oct 7 · completed session · 28h old · Scheduled each trading day · Markets closed · resumes Fri 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is DRUG moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move DRUG next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Oct 7
Score
Score moved +10
32/Lower range -> 42/Lower range
Veridion score historySource

About Bright Minds Biosciences Inc

Biotechnology

Listed since

2021

Employees

Country

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$51.01

Day high

$52.64

Day low

$49.29

Previous close

$52.00

52W high

$95.98

-45.82% from high

52W low

$48.25

8% of range

Market cap

$512.9M

EPS

$-2.9035

Beta

1.19

Shares out

9.9M

Volume

67.9K

0.60× rel vol

Avg volume

113.7K

VWAP

$51.31

Price history computed in-house

+2.58%

-20.07%

-33.20%

-15.32%

YTD

-33.37%

SMA 50 $67.35 · below

SMA 200 $75.82 · below

52W position 8%

DRUG overview

Veridion Score

Registered · 2026-10-07

5 of 6 factors measured

Latest receipt rows

No recent disclosure on file.

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around DRUG.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

DRUG insider activity

Bright Minds Biosciences Inc

90 days, by filing date. Snapshot as of 2026-10-08T23:29:28.642Z.

Score

Not evaluated

Pressure

Not evaluated

Transactions

Unavailable

Filings

Unavailable

Buys / sells

Unavailable

Net value

Not evaluated

Insiders

Unavailable

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

Form 4 evidence state

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in DRUG

Congress tracker Open ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

DRUG contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for DRUG in this window.

Lobbying spend

DRUG lobbying filings, year to date.

Registered lobbying filings matched to Bright Minds Biosciences Inc.

Not disclosed

Refresh interval: 12hSource: LDA disclosure filings

No lobbying filings on file for DRUG in this window.

Analyst ratings

Sovereign unlock shows live analyst consensus for DRUG.

Options

Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.

Related tickers

Cross-references from this score page.

Apprentice · 1 rail

Similar headline score

Nearest public composite scores. Factor similarity requires Sovereign.

Methodology

No related ticker met the data requirements for this rail.

Follow $DRUG

Why is DRUG moving today?

What can move DRUG next.

DRUG overview

Related filings and maps

DRUG insider activity

DRUG contract awards, year to date.

DRUG lobbying filings, year to date.

Cross-references from this score page.

What can move DRUG next.

DRUG insider activity

Cross-references from this score page.